Literature DB >> 12574394

Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.

Fumio Yanai1, Eiichi Ishii, Kensuke Kojima, Atsuhiko Hasegawa, Taichi Azuma, Shinichi Hirose, Naohiro Suga, Akihisa Mitsudome, Masafumi Zaitsu, Yasushi Ishida, Yuji Shirakata, Koji Sayama, Koji Hashimoto, Masaki Yasukawa.   

Abstract

Although the cytotoxic mechanisms of murine CTLs have been investigated extensively using various mutant and knockout mice, those of human CTLs, especially CD4+ CTLs, are still obscure. To clarify the roles of perforin in Ag-specific cytotoxicity mediated by human CD4+ CTLs, alloantigen-specific and HSV-specific human CD4+ T lymphocyte bulk lines and clones were established from a patient with hereditary perforin deficiency and her healthy father, and their cytotoxic activities were investigated. Alloantigen-specific CD4+ T lymphocytes expressing perforin exerted cytotoxicity against Fas-negative as well as Fas-positive allogeneic B lymphoblastoid cell lines established from members of a family with hereditary Fas deficiency. Perforin-deficient, but not perforin-expressing, CD4+ T lymphocytes failed to show strong cytotoxicity against HSV-infected autologous B lymphoblastoid cells. Perforin-deficient CD4+ T lymphocytes could exert relatively low level cytotoxicity against allogeneic IFN-gamma-treated keratinocytes. Although cytotoxicity mediated by perforin-expressing CD4+ CTLs was almost completely inhibited by concanamycin A, a potent inhibitor of the perforin-mediated cytotoxic pathway, cytotoxicity against IFN-gamma-treated keratinocytes mediated by perforin-deficient CD4+ T lymphocytes was inhibited only partially by concanamycin A, but was inhibited significantly by antagonistic anti-Fas Ab and anti-Fas ligand Ab. The combination of perforin-deficient effector T lymphocytes and Fas-negative target cells used in the present study provides a novel experimental system for studying the detailed mechanisms of human CTL-mediated cytotoxicity. The present data demonstrate that perforin-negative CD4+ CTLs can exert cytotoxicity against Fas-sensitive target cells; however, perforin plays essential roles in Ag-specific cytotoxicity mediated by human CD4+ as well as CD8+ CTLs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574394     DOI: 10.4049/jimmunol.170.4.2205

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.

Authors:  Deborah M Brown
Journal:  Cell Immunol       Date:  2010-02-24       Impact factor: 4.868

2.  IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection.

Authors:  Magali M Moretto; Louis M Weiss; Crescent L Combe; Imtiaz A Khan
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Familial hemophagocytic lymphohistiocytosis with the MUNC13-4 mutation: a case report.

Authors:  Hiroshi Mizumoto; Daisuke Hata; Ken Yamamoto; Ryutaro Shirakawa; Akira Kumakura; Mitsutaka Shiota; Atsushi Yokoyama; Hiroshi Matsubara; Michihiro Kobayashi; Ryuta Nishikomori; Soichi Adachi; Tatsutoshi Nakahata; Toru Kita; Hisanori Horiuchi; Masaki Yasukawa; Eiichi Ishii
Journal:  Eur J Pediatr       Date:  2006-01-14       Impact factor: 3.183

4.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

Review 5.  Cytolytic CD4(+) T cells in viral immunity.

Authors:  Damien Z Soghoian; Hendrik Streeck
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

6.  Clinical and genetic characteristics of XIAP deficiency in Japan.

Authors:  Xi Yang; Hirokazu Kanegane; Naonori Nishida; Toshihiko Imamura; Kazuko Hamamoto; Ritsuko Miyashita; Kohsuke Imai; Shigeaki Nonoyama; Kazunori Sanayama; Akiko Yamaide; Fumiyo Kato; Kozo Nagai; Eiichi Ishii; Menno C van Zelm; Sylvain Latour; Xiao-Dong Zhao; Toshio Miyawaki
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

7.  Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes.

Authors:  Kozo Nagai; Ken Yamamoto; Hiroshi Fujiwara; Jun An; Toshiki Ochi; Koichiro Suemori; Takahiro Yasumi; Hisamichi Tauchi; Katsuyoshi Koh; Maho Sato; Akira Morimoto; Toshio Heike; Eiichi Ishii; Masaki Yasukawa
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

Authors:  Jacob Couturier; Alexander T Hutchison; Miguel A Medina; Cosmina Gingaras; Petri Urvil; Xiaoying Yu; Chi Nguyen; Parag Mahale; Lin Lin; Claudia A Kozinetz; Joern E Schmitz; Jason T Kimata; Tor C Savidge; Dorothy E Lewis
Journal:  Virology       Date:  2014-07-04       Impact factor: 3.616

9.  Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.

Authors:  Bruna C G de Alencar; Pedro M Persechini; Filipe A Haolla; Gabriel de Oliveira; Jaline C Silverio; Joseli Lannes-Vieira; Alexandre V Machado; Ricardo T Gazzinelli; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

10.  Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus.

Authors:  Norifumi Iijima; Melissa M Linehan; Melodie Zamora; Debbie Butkus; Robert Dunn; Marilyn R Kehry; Terri M Laufer; Akiko Iwasaki
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.